Curis私募定价为8080万美元

2026-01-07 22:38

Curis (NASDAQ:CRIS) on Wednesday entered into a securities purchase agreement for a private investment in public equity (PIPE) for up to $80.8M in gross proceeds, including approximately $20.2M in initial gross proceeds, which is expected to close on January 8, 2026.
Laidlaw & Company is acting as sole placement agent for the PIPE financing.
Pursuant to the agreement, the company sells 20,195 shares of Series B convertible non-redeemable preferred stock, including Series A, B, and C warrants to purchase approximately 1,333.33 shares of common stock per warrant series, representing up to 26.93M shares per warrant series in the aggregate. All warrants have an exercise price of $0.75 per share.
The securities will be sold at a purchase price of $1,000 per security to the investors.
The Series A warrants will terminate on January 8, 2031, the Series B warrants will terminate subject to certain specified exceptions, and the Series C warrants will terminate on July 8, 2027.
The company intends to use the initial net proceeds, together with existing cash and cash equivalents, to fund research and development, general corporate purposes, and working capital.

More on Curis